Clinical Trial Update: A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy [Phase 3]

View source ↗

Summary

This update confirms the completion of a Phase 3 study evaluating REGN1908-1909 for reducing ocular allergy signs and symptoms in adults with cat allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Cat Allergy

Drugs mentioned

• REGN1908-1909

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED